WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for TGTX

Based on 3 analysts offering 12 month price targets for Tg Therapeutics Inc.
Min Forecast
$5.00-40.26%
Avg Forecast
$13.67+63.29%
Max Forecast
$19.00+127%

Should I buy or sell TGTX stock?

Based on 3 analysts offering ratings for Tg Therapeutics Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
1 analysts 33.33%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TGTX stock forecasts and price targets.

TGTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
B. Riley Securities
Top 1%
100
Strong BuyMaintains$17.00+103.11%2022-06-13
Bank of America
Top 23%
78
SellInitiates Coverage On$5.00-40.26%2022-05-20
Anonymous
Goldman Sachs
Strong SellMaintains$5.00-40.26%2022-04-19
HC Wainwright & Co.
Top 22%
79
BuyMaintains$19.00+127.00%2022-04-18

1 of 1

Forecast return on equity

Is TGTX forecast to generate an efficient return?
Company
40.5%
Industry
15.35%
Market
62.84%
TGTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TGTX forecast to generate an efficient return on assets?
Company
18.68%
Industry
13.55%
TGTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TGTX earnings per share forecast

What is TGTX's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
-$1.77
Avg 2 year Forecast
-$1.51
Avg 3 year Forecast
-$0.67

TGTX revenue forecast

What is TGTX's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$16.6M+231.12%
Avg 2 year Forecast
$92.9M+1,748.06%
Avg 3 year Forecast
$194.9M+3,778.95%
TGTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TGTX revenue growth forecast

How is TGTX forecast to perform vs Biotechnology companies and vs the US market?
Company
236%
Industry
24.83%
Market
6.69%
TGTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TGTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TGTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TGTX$8.37$13.67+63.29%Buy
BLU$9.68$20.50+111.78%Strong Buy
IMGO$35.86$36.00+0.39%Hold
MNKD$4.57$6.00+31.29%Buy
IOVA$7.59$24.00+216.21%Buy

Tg Therapeutics Stock Forecast FAQ

Is Tg Therapeutics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: TGTX) stock is to Buy TGTX stock.

Out of 3 analysts, 1 (33.33%) are recommending TGTX as a Strong Buy, 1 (33.33%) are recommending TGTX as a Buy, 0 (0%) are recommending TGTX as a Hold, 1 (33.33%) are recommending TGTX as a Sell, and 0 (0%) are recommending TGTX as a Strong Sell.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.

What is TGTX's earnings growth forecast for 2022-2024?

(NASDAQ: TGTX) Tg Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Tg Therapeutics's earnings in 2022 is -$238,679,000.On average, 7 Wall Street analysts forecast TGTX's earnings for 2022 to be -$257,255,282, with the lowest TGTX earnings forecast at -$523,231,081, and the highest TGTX earnings forecast at -$132,261,190. On average, 7 Wall Street analysts forecast TGTX's earnings for 2023 to be -$219,466,370, with the lowest TGTX earnings forecast at -$513,057,144, and the highest TGTX earnings forecast at -$120,633,833.

In 2024, TGTX is forecast to generate -$97,379,118 in earnings, with the lowest earnings forecast at -$109,006,475 and the highest earnings forecast at -$85,751,761.

What is TGTX's revenue growth forecast for 2022-2024?

(NASDAQ: TGTX) Tg Therapeutics's forecast annual revenue growth rate of 236% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Tg Therapeutics's revenue in 2022 is $5,025,000.On average, 4 Wall Street analysts forecast TGTX's revenue for 2022 to be $2,418,344,989, with the lowest TGTX revenue forecast at $390,388,523, and the highest TGTX revenue forecast at $8,383,760,682. On average, 4 Wall Street analysts forecast TGTX's revenue for 2023 to be $13,497,181,765, with the lowest TGTX revenue forecast at $6,726,426,233, and the highest TGTX revenue forecast at $23,807,014,195.

In 2024, TGTX is forecast to generate $28,329,620,182 in revenue, with the lowest revenue forecast at $14,083,636,602 and the highest revenue forecast at $40,265,538,538.

What is TGTX's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: TGTX) forecast ROA is 18.68%, which is higher than the forecast US Biotechnology industry average of 13.55%.

What is TGTX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year TGTX price target, the average TGTX price target is $13.67, with the highest TGTX stock price forecast at $19.00 and the lowest TGTX stock price forecast at $5.00.

On average, Wall Street analysts predict that Tg Therapeutics's share price could reach $13.67 by Jun 13, 2023. The average Tg Therapeutics stock price prediction forecasts a potential upside of 63.29% from the current TGTX share price of $8.37.

What is TGTX's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: TGTX) Tg Therapeutics's current Earnings Per Share (EPS) is -$1.77. On average, analysts forecast that TGTX's EPS will be -$1.77 for 2022, with the lowest EPS forecast at -$3.60, and the highest EPS forecast at -$0.91. On average, analysts forecast that TGTX's EPS will be -$1.51 for 2023, with the lowest EPS forecast at -$3.53, and the highest EPS forecast at -$0.83. In 2024, TGTX's EPS is forecast to hit -$0.67 (min: -$0.75, max: -$0.59).

What is TGTX's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: TGTX) forecast ROE is 40.5%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.